FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to biochemistry and represents versions of monoclonal anti-TAT226 antibodies, their immunoconjugates and pharmaceutical compositions.
EFFECT: antibodies by invention can be efficiently applied for inhibition of tumour cell proliferation.
41 cl, 22 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES AND IMMUNOCONJUGATES AND THEIR APPLICATION | 2007 |
|
RU2436796C9 |
| ANTIBODIES AND IMMUNOCONJUGATES AND THEIR APPLICATIONS | 2007 |
|
RU2639543C9 |
| ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2008 |
|
RU2511410C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2009 |
|
RU2553566C2 |
| H7N9 INFLUENZA A THERAPY | 2015 |
|
RU2682049C2 |
| ANTIBODIES AGAINST 5-BROMO-2'-DEOXYURIDINE AND METHODS OF USE | 2015 |
|
RU2705299C2 |
| ANTIBODY-DRUG CONJUGATES AND METHODS OF USING SAID CONJUGATES OF PYRROLOBENZODIAZEPINE | 2016 |
|
RU2736725C1 |
| ANTI-FcRH5 ANTIBODIES | 2014 |
|
RU2687132C2 |
| STABLE COMPOSITIONS OF IMMUNOCONJUGATES CONTAINING ANTIBODIES TO CD79b | 2019 |
|
RU2800803C2 |
